TCT-65 Two-Year Outcomes in Real-World Patients Treated With a Thin-Strut, Platinum-Chromium, Everolimus-Eluting Stent in the PROMUS Element Plus US Post-Approval Study (PE-Plus PAS)

TCT-65 Two-Year Outcomes in Real-World Patients Treated With a Thin-Strut, Platinum-Chromium, Everolimus-Eluting Stent in the PROMUS Element Plus US Post-Approval Study (PE-Plus PAS)

Background The PE Plus Post-Approval Study (PE Plus PAS) was designed to examine long-term outcomes among patients treated with advanced generation, everolimus-eluting, platinum chromium PROMUS Element stents (Boston Scientific, Marlborough, MA) in unselected patients treated in routine practice.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2015-10, Vol.66 (15), p.B29-B29
Hauptverfasser: Kandzari, David, Siachos, A. Thomas, Tami, Luis F, Watt, Bruce, Goodroe, Randall, Pow, Thomas K, Hill, Roger, Haghighat, Amir, Christen, Thomas, Allocco, Dominic J, Dawkins, Keith D
Format: Artikel
Sprache:eng
Schlagworte:
Angioplasty
Cardiology
Cardiovascular
Cardiovascular disease
Confidence intervals
Heart attacks
Internal Medicine
Stents
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background The PE Plus Post-Approval Study (PE Plus PAS) was designed to examine long-term outcomes among patients treated with advanced generation, everolimus-eluting, platinum chromium PROMUS Element stents (Boston Scientific, Marlborough, MA) in unselected patients treated in routine practice.
ISSN:0735-1097
1558-3597
DOI:10.1016/j.jacc.2015.08.910